Niels-Stensen-Kliniken GmbH

How German vascular surgeons and angiologists judge walking exercise for patients with PAD: Results from a nationwide survey amongst 743 members of two major scientific societies (2023) Rother U, Dörr G, Malyar N, Müller OJ, Steinbauer M, Ito W, Cotta L, et al. Journal article Can Synthetic Images Improve CNN Performance in Wound Image Classification? (2023) Malihi L, Hübner U, Richter ML, Moelleken M, Przysucha M, Busch D, Heggemann J, et al. Book chapter / Article in edited volumes Best Practice Guideline - DEGUM Recommendations on Breast Ultrasound PART II Additive and Optional Application Modalities in Breast Ultrasound, Quality Assurance (2023) Vogel-Minea CM, Bader W, Blohmer JU, Duda V, Eichler C, Fallenberg EM, Farrokh A, et al. Journal article Clinical Results and Quality of Life After Transcortical Versus Transcallosal Resection of Adult Lateral and Third Ventricle Lesions: Long-Term Outcome (2023) AlSharif M, Stroop R, Scholz M, Buchfelder M, Wiendieck K, Shiban E, Sommer B Journal article Automatic Wound Type Classification with Convolutional Neural Networks (2022) Malihi L, Hüsers J, Richter ML, Moelleken M, Przysucha M, Busch D, Heggemann J, et al. Book chapter / Article in edited volumes An Image Based Object Recognition System for Wound Detection and Classification of Diabetic Foot and Venous Leg Ulcers. (2022) Hüsers J, Moelleken M, Richter ML, Przysucha M, Malihi L, Busch D, Götz NA, et al. Journal article Automatic Classification of Diabetic Foot Ulcer Images - A Transfer-Learning Approach to Detect Wound Maceration (2022) Hüsers J, Hafer G, Heggemann J, Wiemeyer S, Przysucha M, Dissemond J, Moelleken M, et al. Conference contribution TROPHY registry — status report (2021) Thomale UW, Auer C, Spennato P, Schaumann A, Behrens P, Gorelyshev S, Bogoslovskaia E, et al. Journal article First German Guideline on Diagnostics and Therapy of Clinically Non-Functioning Pituitary Tumors (2021) Deutschbein T, Jaursch-Hancke C, Knappe UJ, Saeger W, Flitsch J, Bojunga J, Buchfelder M, et al. Journal article Real-world efficacy of ribociclib plus aromatase inhibitor/fulvestrant, or endocrine monotherapy, or chemotherapy as first-line treatment in women with HR-positive, HER2-negative locally advanced or metastatic breast cancer: Third interim analysis from the RIBANNA study (2021) Wockel A, Brucker C, Decker T, Falbrede J, Forstbauer H, Gohler T, Hoffmann O, et al. Conference contribution